News

FIRST TEAM grant for Dr Paweł Mikulski to develop a new therapy for liver cancer

Dr Paweł Mikulski from the Nencki Institute has received a FIRST TEAM grant from the Foundation for Polish Science to carry out the project “Development of an innovative molecule for a new type of immunotherapy for hepatocellular carcinoma.” Hepatocellular carcinoma (HCC) is the fifth most common and the third deadliest type of cancer worldwide, causing approximately 0.8 million deaths each year. Current treatments for HCC are either ineffective or associated with significant clinical ...